[
  {
    "date": "2022-07-30",
    "symbol": "BCTXW",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentperiodenddate": "July 31, 2022",
    "documentfiscalperiodfocus": "FY",
    "documentfiscalyearfocus": 2022,
    "currentfiscalyearenddate": "July 31",
    "entityfilenumber": "001-40101",
    "entityregistrantname": "BRIACELL THERAPEUTICS CORP.",
    "entitycentralindexkey": 1610820,
    "entitytaxidentificationnumber": "47-1099599",
    "entityincorporationstatecountrycode": "A1",
    "entityaddressaddressline1": "Suite                                            300 â€“ 235 15th Street",
    "entityaddresscityortown": "West    Vancouver",
    "entityaddressstateorprovince": "BC",
    "entityaddresspostalzipcode": "V7T 2X1",
    "cityareacode": "(604)",
    "localphonenumber": "921-1810",
    "security12btitle": "Warrants to purchase    common shares, no par value",
    "securityexchangename": "NASDAQ",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Non-accelerated    filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "false",
    "entityshellcompany": "No",
    "icfrauditorattestationflag": "false",
    "auditorfirmid": 1930,
    "auditorname": "MNPLLP",
    "auditorlocation": "Mississauga,Canada",
    "cashandcashequivalentsatcarryingvalue": "null",
    "accountsreceivablenetcurrent": 24103,
    "prepaidexpensecurrent": "null",
    "assetscurrent": "null",
    "equitymethodinvestments": 2,
    "finitelivedintangibleassetsnet": 230339,
    "assetsnoncurrent": 230341,
    "assets": "null",
    "accountspayabletradecurrent": 463280,
    "accountspayableandotheraccruedliabilitiescurrent": 477807,
    "liabilitiescurrent": 941087,
    "warrantliabilitynoncurrent": "null",
    "liabilitiesnoncurrent": "null",
    "commonstockvalue": "null",
    "additionalpaidincapitalcommonstock": "null",
    "accumulatedothercomprehensiveincomelossnetoftax": -138684,
    "retainedearningsaccumulateddeficit": "-null",
    "stockholdersequity": "-null",
    "liabilitiesandstockholdersequity": "null",
    "commonstocksharesauthorizedunlimited": "Unlimited",
    "commonstocksharesissued": "null",
    "commonstocksharesoutstanding": "null",
    "researchanddevelopmentexpense": 435563,
    "generalandadministrativeexpense": "null",
    "operatingincomeloss": "-null",
    "financialexpensenet": "-null",
    "netincomeloss": "-null",
    "earningspersharebasic": -1.73,
    "weightedaveragenumberofsharesoutstandingbasic": "null",
    "sharesoutstanding": "null",
    "stockissuedduringperiodsharesnewissues": "null",
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationstockoptionsrequisiteserviceperiodrecognition": "null",
    "stockissuedduringperiodvalueexerciseofbrokerwarrants": "null",
    "stockissuedduringperiodsharesexerciseofbrokerwarrants": 219453,
    "stockissuedduringperiodvalueprivateplacementwarrants": "null",
    "stockissuedduringperiodsharesprivateplacementwarrants": 997200,
    "stockissuedduringperiodvaluepublicofferingwarrants": 683905,
    "stockissuedduringperiodsharespublicofferingwarrants": 63454,
    "stockissuedduringperiodvalueissuancecosts": -57116,
    "stockrepurchasedduringperiodvalue": "null",
    "stockrepurchasedduringperiodshares": "null",
    "adjustmentstoadditionalpaidincapitalexpirationofoptions": 24554,
    "depreciationdepletionandamortization": 15272,
    "sharebasedcompensation": "null",
    "interestexpense": 979,
    "gainfromgovernmentgrant": -3388,
    "fairvalueadjustmentofwarrants": "null",
    "increasedecreaseinaccountsreceivable": 11530,
    "increasedecreaseinprepaidexpense": 764054,
    "increasedecreaseinaccountspayable": 249164,
    "increasedecreaseinotheraccountspayableandaccruedliabilities": 135128,
    "netcashprovidedbyusedinoperatingactivities": "-null",
    "proceedsfromwarrantexercises": "null",
    "paymentsforrepurchaseofequity": "null",
    "repaymentgovernmentgrant": 23577,
    "paymentsofstockissuancecosts": 57116,
    "netcashprovidedbyusedinfinancingactivities": "-null",
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseexcludingexchangerateeffect": "-null",
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": "null",
    "propertyplantandequipmentsalvagevaluepercentage": 0.33,
    "finitelivedintangibleassetusefullife": 20,
    "finitelivedintangibleassetsamortizationmethod": "Straight-line",
    "finitelivedintangibleassetsinhousedevelopmentorpurchase": "Purchase",
    "propertyplantandequipmentnet": 2500,
    "finitelivedpatentsgross": 305130,
    "finitelivedintangibleassetsgross": 305130,
    "finitelivedintangibleassetsaccumulatedamortization": 74791,
    "finitelivedintangibleassetsamortizationexpensenexttwelvemonths": 15271,
    "finitelivedintangibleassetsamortizationexpenseyeartwo": 15271,
    "finitelivedintangibleassetsamortizationexpenseyearthree": 15271,
    "finitelivedintangibleassetsamortizationexpenseyearfour": 15271,
    "finitelivedintangibleassetsamortizationexpenseyearfive": 15271,
    "finitelivedintangibleassetsamortizationexpenseafteryearfive": 153984,
    "amortizationofintangibleassets": 15271,
    "classofwarrantorrightnumberofsecuritiescalledbywarrantsorrights": 46652,
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 6.19,
    "warrantsandrightsoutstanding": "null",
    "costsandexpenses": 26907,
    "accruedclinicalactivities": 69720,
    "accruedprofessionalfeescurrent": 408087,
    "assetsfairvaluedisclosure": "null",
    "liabilitiesfairvaluedisclosure": "null",
    "shareprice": 6.5,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexerciseprice": 6.19,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": 8,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.65,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0268,
    "proceedsfromissuanceofwarrantbuybackprogram": "-null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsoutstandingnumber": "null",
    "weightedaverageexercisepriceoutstandingbalance": 5.76,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsexpirations": 22489,
    "weightedaverageexercisepriceexpired": 28.08,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsexercised": 554991,
    "weightedaverageexercisepriceexercised": 6.14,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 999,
    "weightedaverageexercisepricerepurchasedandcancelled": 5.31,
    "classofwarrantorrightoutstanding": 46652,
    "classofwarrantorrighstdatefromwhichwarrantsorrightsexercisable": "June 7, 2026",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 6.2,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 7.81,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexpirationsinperiodweightedaverageexerciseprice": 46.8,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 5.68,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": "null",
    "gainlossonfairvalueofwarrantliability": "null",
    "compensationofwarrants": 554991,
    "increasedecreaseinfairvalueofwarrants": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingperiodincreasedecreaseweightedaverageexerciseprice": 5.68,
    "stockissuedduringperiodsharescashlessexerciseofwarrants": 219453,
    "publiclytradedwarrants": 243323,
    "publiclytradedwarrantsvalue": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrateminimum": 0.013999999999999999,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestratemaximum": 0.015,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": 3.91,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 447090,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 818300,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualgranted": 4.44,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 30.04,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexpirationsinperiod": 1667,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm1": 4.09,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 5.83,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": 3.99,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 805367,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeoutstandingoptionsweightedaverageexercisepricebeginningbalance1": 4.24,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangenumberofoutstandingoptions": "null",
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeoutstandingoptionsweightedaverageremainingcontractualterm2": 3.72,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangenumberofexercisableoptions": "null",
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeexercisableoptionsweightedaverageremainingcontractualterm2": 3.72,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationdate": "April 19, 2026",
    "acquiringpercentageofissuedandoutstandingofcommonstock": 0.1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantedinperiod": "5 years",
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": "null",
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": 1.75,
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": "-null",
    "incomelossfromcontinuingoperationsbeforeincometaxesforeign": "-null",
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": "-null",
    "incometaxreconciliationnondeductibleexpenseother": "-null",
    "incometaxreconciliationchangeinenactedtaxrate": "null",
    "incometaxreconciliationnondeductibleexpensesharebasedcompensationcost": 828930,
    "incometaxreconciliationrepatriationofforeignearnings": 7810,
    "incometaxreconciliationequityinearningslossesofunconsolidatedsubsidiary": -15420,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": "null",
    "deferredtaxassetspropertyplantandequipment": 730,
    "deferredtaxassetsmarketablesecurities": 11760,
    "deferredtaxassetswarrantliability": "null",
    "deferredtaxassetstaxdeferredexpense": "null",
    "deferredtaxassetsotherlosscarryforwards": "null",
    "deferredtaxassetsoperatinglosscarryforwards": "null",
    "deferredtaxassetsgross": "null",
    "deferredtaxassetsvaluationallowance": "null",
    "deferredtaxassetsnet": 48370,
    "deferredtaxliabilitiespropertyplantandequipment": 48370,
    "deferredincometaxliabilities": 48370,
    "operatinglosscarryforwards": "null",
    "operatinglosscarryforwardexpirationdatedescription": "Thefederal net operating losses have expiry periods ranging between 2033 and indefinitely.",
    "deferredtaxassetsoperatinglosscarryforwardsforeign": "null",
    "foreignoperatinglosscarryforwardexpirationdatedescription": "TheCanadian net operating losses have expiry periods ranging between 2035 and 2042.",
    "relatedpartycosts": "null",
    "relatedpartytransactionduefromtorelatedparty": 75558,
    "investmentincomeinterest": 136731,
    "gainongovernmentgrant": 3388,
    "foreigncurrencytransactiongainlossbeforetax": -30730,
    "nonoperatingincomeexpense": "-null",
    "netincomelossavailabletocommonstockholdersbasic": "-null",
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": "null",
    "noncurrentassets": 230340
  }
]